Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.
Schiff AE, Wang X, Patel NJ, Kawano Y, Hanberg JL, Kowalski EN, Cook CE, Vanni KM, Qian G, Bade KJ, Saavedra AA, Srivatsan S, Williams ZK, Venkat RK, Wallace ZS, Sparks JA. Schiff AE, et al. Among authors: kowalski en. Ann Rheum Dis. 2024 Apr 11;83(5):680-682. doi: 10.1136/ard-2023-225162. Ann Rheum Dis. 2024. PMID: 38199795 No abstract available.
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study.
Di Iorio M, Cook CE, Vanni KMM, Patel NJ, D'Silva KM, Fu X, Wang J, Prisco LC, Kowalski E, Zaccardelli A, Martin LW, Qian G, Hsu TY, Wallace ZS, Sparks JA. Di Iorio M, et al. medRxiv [Preprint]. 2022 Feb 9:2022.02.08.22270696. doi: 10.1101/2022.02.08.22270696. medRxiv. 2022. Update in: Semin Arthritis Rheum. 2022 Aug;55:152025. doi: 10.1016/j.semarthrit.2022.152025 PMID: 35169813 Free PMC article. Updated. Preprint.
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.
Liew J, Gianfrancesco M, Harrison C, Izadi Z, Rush S, Lawson-Tovey S, Jacobsohn L, Ja C, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Schäfer M, Frãzao-Mateus E, Bulina I, Stafford F, Tufan A, Graver C, Yardımcı GK, Zepa J, Al Emadi S, Cook C, Abutiban F, Dey D, Katigbak G, Kaufman L, Kowalski E, Martínez-Martínez MU, Patel NJ, Reyes-Cordero G, Salido E, Smith E, Snow D, Sparks J, Wise L, Bhana S, Gore-Massy M, Grainger R, Hausmann J, Sirotich E, Sufka P, Wallace Z, Machado PM, Robinson PC, Yazdany J. Liew J, et al. RMD Open. 2022 Apr;8(1):e002187. doi: 10.1136/rmdopen-2021-002187. RMD Open. 2022. PMID: 35387864 Free PMC article.
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study.
Di Iorio M, Cook CE, Vanni KMM, Patel NJ, D'Silva KM, Fu X, Wang J, Prisco LC, Kowalski E, Zaccardelli A, Martin LW, Qian G, Hsu TY, Wallace ZS, Sparks JA. Di Iorio M, et al. Semin Arthritis Rheum. 2022 Aug;55:152025. doi: 10.1016/j.semarthrit.2022.152025. Epub 2022 May 18. Semin Arthritis Rheum. 2022. PMID: 35617780 Free PMC article.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron.
Kawano Y, Patel NJ, Wang X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Qian G, DiIorio M, Hsu TYT, Weinblatt ME, Todd DJ, Wallace ZS, Sparks JA. Kawano Y, et al. Among authors: kowalski en. medRxiv [Preprint]. 2022 Jun 20:2022.06.19.22276599. doi: 10.1101/2022.06.19.22276599. medRxiv. 2022. Update in: Ann Rheum Dis. 2022 Dec;81(12):1742-1749. doi: 10.1136/ard-2022-222954 PMID: 35765565 Free PMC article. Updated. Preprint.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave.
Kawano Y, Patel NJ, Wang X, Cook CE, Vanni KM, Kowalski EN, Banasiak EP, Qian G, DiIorio M, Hsu TY, Weinblatt ME, Todd DJ, Wallace ZS, Sparks JA. Kawano Y, et al. Among authors: kowalski en. Ann Rheum Dis. 2022 Dec;81(12):1742-1749. doi: 10.1136/ard-2022-222954. Epub 2022 Aug 9. Ann Rheum Dis. 2022. PMID: 35944947 Free PMC article.
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study.
Figueroa-Parra G, Gilbert EL, Valenzuela-Almada MO, Vallejo S, Neville MR, Patel NJ, Cook C, Fu X, Hagi R, McDermott GC, Dilorio MA, Masto L, Vanni KMM, Kowalski E, Qian G, Zhang Y, Wallace ZS, Duarte-García A, Sparks JA. Figueroa-Parra G, et al. Lancet Rheumatol. 2022 Nov;4(11):e765-e774. doi: 10.1016/S2665-9913(22)00227-2. Epub 2022 Sep 13. Lancet Rheumatol. 2022. PMID: 36118532 Free PMC article.
Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19.
Herman JD, Atyeo C, Zur Y, Cook CE, Patel NJ, Vanni KM, Kowalski EN, Qian G, Shadick NA, Laffenburger D, Wallace ZS, Sparks JA, Alter G. Herman JD, et al. Among authors: kowalski en. medRxiv [Preprint]. 2022 Sep 26:2022.09.25.22280335. doi: 10.1101/2022.09.25.22280335. medRxiv. 2022. PMID: 36203557 Free PMC article. Preprint.
29 results